
Resveratrol shows promise as a chemoprotective and photoprotective agent in human skin cells, authors of a recent study say.

Resveratrol shows promise as a chemoprotective and photoprotective agent in human skin cells, authors of a recent study say.

Rosacea patients comprise the biggest group of individuals with sensitive skin. This sensitive skin is thought to be due, in part, to a defective barrier and vasomotor instability. Thus, any topically applied substance that causes noxious sensory stimuli, vasodilation or irritation can result in a rosacea flare.

Rosacea is a common skin disorder that affects 14 million Americans. Though the condition is sometimes mild in nature, many patients with rosacea have lower self-esteem and tend to avoid public contact or cancel social engagements.

Patients' enduring interest in tumescent liposuction and noninvasive procedures indicates there's a fertile market for manufacturers to explore, an expert says.

Today, many consumers are choosing to fight aging from the inside by using nutricosmetics, such as drinks, supplements and foods that claim to slow the visible signs of aging. But some precautions are in order, according to one expert.

Both ablative and nonablative technologies can rejuvenate the skin. They can also be used to treat acne scarring. Nonablative technologies like intense pulsed light can treat brown spots and control redness associated with rosacea.

A cadaveric study highlighting the link between solar elastosis and adenoid (reticulated) seborrheic keratosis suggests minute superficial shave biopsies of adenoid seborrheic keratoses could miss peripheral pigmented actinic keratosis and solar lentigines, a study co-author says.

Finding a consensus on the classification of cicatricial alopecia can help physicians better communicate with each other. Quicker recognition of disease will allow patients to be treated earlier and improve treatment outcomes.

Physicians will soon have an expanded array of injectables, as manufacturers fine-tune fillers and bring new neurotoxins to the market.

Unusual and rare presentations of tinea capitis can sometimes mimic cicatricial alopecia. According to one expert, it is important to consider all possible diagnoses and especially rule out a fungal scalp disease, no matter how suspicious the clinical presentation may be.

Arlington, Va. - Little is known about the obscure disease group of alopecias known as cicatricial alopecia, or scarring alopecia, and to date, an effective therapy for this hair loss disease group largely remains elusive. According to one expert in the field, diagnosing the disease early is key to halting or slowing the progression of the hair loss.

Schaumburg, Ill. - Dermatology Times has won five 2009 Gold Triangle awards from the American Academy of Dermatology (AAD).

At any given time, thousands of dermatologic studies are ongoing, and hundreds are reaching the publishing stage.

The outline of plans to reform healthcare that may be developed under the Obama presidency is beginning to take shape, and while there no doubt will be positive developments for dermatologists, there are also some areas that could cause concern.

Dr. Records has a large dermatology practice in the Sunbelt. He is known as an expert skin cancer doctor and does thousands of body exams every year.

During the Congress of the European Academy of Dermatology and Venereology, the European Society for Micrographic Surgery discussed the growing problem of skin cancer. We would like to share our thoughts about the increasing number of skin cancer patients and how to deal with this problem.

My friend and colleague, Ted Miller, recently related a story about one of his patients, who was 92 years old and had consulted with another dermatologist about several growths on his face.

New York - The Food and Drug Administration (FDA) has held off making a decision on the psoriasis drug ustekinumab (Johnson & Johnson), until they receive certain risk-mitigation information, but will not require new studies, Reuters reports.

Taipei, Taiwan - Researchers have found that psoriasis patients show high levels of leptin, increasing the chances of other inflammatory diseases associated with this metabolic hormone, Medpage Today reports.

Like many doctors, I’ve been considering getting a "smart phone," such as an iPhone or Blackberry, which can surf the Internet and handle e-mail with ease. Why wait?

Dermatology Times Podcast Center

Ness Ziona, Israel - Sol-Gel Technologies unveiled a new plant with state-of-the-art facilities for the development of topical dermatology drugs, according to a press release.

Washington - The Food and Drug Administration (FDA) is requiring Targanta Therapeutics to conduct an additional phase 3 trial of its antibiotic oritavancin, according to fdanews.com.

Washington - Researchers have found two simple blood tests can help physicians diagnose "flesh-eating bacteria," according to a study published in The American Journal of Surgery.

San Diego - Artes Medical plans to liquidate, after laying off more than 100 people last month and filing for Chapter 7 bankruptcy this week, SignOnSanDiego.com reports.

Schaumburg, Ill. - The American Academy of Dermatology (AAD)has issued a position statement on vitamin D, recommending that the public obtain an adequate amount of the vitamin through dietary supplements and nutritional sources, MarketWatch reports.

Shanghai, China - LEO Pharma is establishing a strategic company in China to market drugs for the treatment of psoriasis and other skin diseases, MarketWatch reports.

U.S. dermatologist Carrie Kovarik, M.D., along with the help of the AAD, has built a successful telecommunication program linking dermatologists in developed countries with clinicians who need advice and consultation to help patients throughout Africa. Plans are for the program to expand in and outside Africa, into Central and South Americas.

SkincareMK09DERM_FINAL.pdf

DERM July08 BPA.pdf